Dorsey Wright & Associates’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$43K Sell
3,151
-192
-6% -$2.55K 0.01% 168
2022
Q1
$46K Sell
3,343
-472
-12% -$6.23K 0.01% 218
2021
Q4
$54K Buy
3,815
+520
+16% +$7.19K 0.01% 226
2021
Q3
$44K Buy
3,295
+260
+9% +$3.5K 0.01% 238
2021
Q2
$43K Buy
+3,035
New +$42.8K 0.01% 232

Other funds holding BIOX

Dorsey Wright & Associates's BIOX Position: Q2 2022 in Review

Dorsey Wright & Associates reduced its Bioceres Crop Solutions (BIOX) stake by 5.7% in Q2 2022, selling an estimated $2.55K and leaving 3,151 shares worth $43K. The position accounts for 0.01% of the portfolio, ranked #168.

Dorsey Wright & Associates first reported a position in BIOX in Q2 2021 and has held it in 5 quarters since. The position peaked at $54K in Q4 2021. 27 funds tracked by Wall St. Rank hold BIOX as of Q2 2022.

  • Dorsey Wright & Associates held 3,151 shares of Bioceres Crop Solutions worth $43K as of Q2 2022.
  • Dorsey Wright & Associates sold 192 Bioceres Crop Solutions shares in Q2 2022, an estimated $2.55K.
  • Bioceres Crop Solutions made up 0.01% of Dorsey Wright & Associates's portfolio in Q2 2022, its #168 holding.
  • Dorsey Wright & Associates first reported a position in Bioceres Crop Solutions in Q2 2021 and has held it in 5 quarters since.
  • Dorsey Wright & Associates's Bioceres Crop Solutions position peaked at $54K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q2 2022.

Based on Dorsey Wright & Associates's 13F filing for Q2 2022, filed 20 Jul 2022.